The Different Faces of the Selective Human Telomerase Inhibitor: BIBR1532 and Its Derivatives. (PubMed, Curr Issues Mol Biol) - Sep 27, 2026 - "Using an in silico approach, we analysed how the structural modification of the BIBR scaffold influences the binding mode at the BIBR binding site recently discovered in the structure of human telomerase. We have also assessed whether reported analogues offer a measurable advantage over the parent compound."
Journal • Oncology
|
|
Iwona Gabriel; Kamila Wolska; Natalia Maciejewska
|